FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Dr Lal PathLabs IPO and S H Kelkar IPO.
Dr Lal PathLabs IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while S H Kelkar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Dr Lal PathLabs IPO | S H Kelkar IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Citigroup Global Markets India Private Limited Kotak Mahindra Capital Company Limited |
Jm Financial Limited Kotak Mahindra Capital Company Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dr Lal PathLabs IPO is up to ₹638.00 Cr whereas the issue size of the S H Kelkar IPO is up to ₹508.17 Cr. The final issue price of Dr Lal PathLabs IPO is ₹550.00 per share and of S H Kelkar IPO is ₹180.00 per share.
Dr Lal PathLabs IPO | S H Kelkar IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹540.00 per share | ₹173.00 per share |
Issue Price (Upper) | ₹550.00 per share | ₹180.00 per share |
Issue Price (Final) | ₹550.00 per share | ₹180.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 20 shares | 80 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹210.00 Cr | |
OFS Issue Size | 1,65,65,161 shares | |
OFS Issue Size (Amount) | ||
Issue Size Total | 1,16,00,000 shares | |
Issue Size Total (Amount) | up to ₹638.00 Cr | up to ₹508.17 Cr |
Dr Lal PathLabs IPO opens on Dec 08, 2015, while S H Kelkar IPO opens on Oct 28, 2015. The closing date of Dr Lal PathLabs IPO and S H Kelkar IPO is Dec 10, 2015, and Oct 30, 2015, respectively.
Dr Lal PathLabs IPO | S H Kelkar IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Dec 08, 2015 | Oct 28, 2015 |
Issue Close | Dec 10, 2015 | Oct 30, 2015 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Dr Lal PathLabs IPO P/E ratio is , as compared to S H Kelkar IPO P/E ratio of .
Dr Lal PathLabs IPO | S H Kelkar IPO | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 63.67% | 64.2% | ||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 58.7% | 56.71% | ||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||
ROE | ||||||||||||||||||||||
ROCE | ||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||
EPS | ||||||||||||||||||||||
RoNW | 27.85%% | 17.7%% |
In the Dr Lal PathLabs IPO retail investors (RII) are offered 40,60,000 shares while in S H Kelkar IPO retail investors are offered 40,60,000 shares. Qualified institutional buyers (QIB) are offered 23,20,000 shares in Dr Lal PathLabs IPO and 58,82,397 shares in S H Kelkar IPO.
Dr Lal PathLabs IPO | S H Kelkar IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 23,20,000 shares | 58,82,397 shares |
NII | 17,40,000 shares | 43,05,583 shares |
RII | 40,60,000 shares | 1,00,46,362 shares |
Employee | ||
Others | ||
Total | 81,20,000 shares | 2,02,34,342 shares |
Dr Lal PathLabs IPO subscribed 33.41x in total, whereas S H Kelkar IPO subscribed 27.00x.
Dr Lal PathLabs IPO | S H Kelkar IPO | |
---|---|---|
QIB (times) | 63.56x | 25.55x |
NII (times) | 61.28x | 87.38x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 4.24x | 1.98x |
Employee (times) | ||
Other (times) | ||
Total (times) | 33.41x | 27.00x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|